Sale!

C12ORF65 Gene SPG55 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The C12ORF65 gene, associated with spastic paraplegia 55 (SPG55), is a critical focus in genetic testing for individuals experiencing symptoms of this inherited condition. Spastic paraplegia 55 is a form of hereditary spastic paraplegia, characterized by progressive weakness and stiffness of the legs. The C12ORF65 gene plays a significant role in mitochondrial function, and mutations in this gene can disrupt cellular energy production, leading to the symptoms observed in SPG55.

DNA Labs UAE offers a specialized genetic test targeting the C12ORF65 gene to diagnose SPG55. This test is essential for individuals presenting symptoms of spastic paraplegia, as it can confirm the diagnosis and help in the management of the condition. The test involves analyzing the patient’s DNA to identify mutations in the C12ORF65 gene that are known to cause SPG55.

The cost of the C12ORF65 gene SPG55 genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of a DNA sample, usually through a blood draw or cheek swab, and the comprehensive analysis of the C12ORF65 gene. Upon completion of the test, a detailed report is provided, outlining the findings and their implications for the patient’s health and treatment options. This genetic test is a valuable tool for affected individuals and their families to understand their genetic makeup and to make informed decisions regarding their health care and management of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

C12ORF65 Gene SPG55 Genetic Test

Cost: AED 4400.0

Symptoms, Diagnosis, and Test Details

The C12ORF65 gene is associated with a rare genetic disorder called spastic paraplegia type 55 (SPG55). SPG55 is a type of hereditary spastic paraplegia, which is characterized by progressive stiffness and weakness in the lower limbs.

NGS (Next-Generation Sequencing) genetic testing can be used to analyze the DNA sequence of the C12ORF65 gene and identify any mutations or variations that may be present. This test can help confirm a diagnosis of SPG55 and provide information about the specific genetic changes involved.

Genetic testing for SPG55 can be beneficial for individuals who have symptoms consistent with the condition, as well as their family members who may be at risk of inheriting the disorder. It can help guide treatment decisions, provide information about prognosis, and assist in family planning.

It’s important to note that genetic testing for SPG55 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Components and Price

  • Test Name: C12ORF65 Gene SPG55 Genetic Test
  • Components: NGS Technology
  • Price: AED 4400.0

Sample Condition and Report Delivery

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type and Doctor

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department and Pre Test Information

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for C12ORF65 Gene SPG55 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with C12ORF65 Gene SPG55.

Test Name C12ORF65 Gene SPG55 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for C12ORF65 Gene SPG55 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with C12ORF65 Gene SPG55
Test Details

The C12ORF65 gene is associated with a rare genetic disorder called spastic paraplegia type 55 (SPG55). SPG55 is a type of hereditary spastic paraplegia, which is characterized by progressive stiffness and weakness in the lower limbs.

NGS (Next-Generation Sequencing) genetic testing can be used to analyze the DNA sequence of the C12ORF65 gene and identify any mutations or variations that may be present. This test can help confirm a diagnosis of SPG55 and provide information about the specific genetic changes involved.

Genetic testing for SPG55 can be beneficial for individuals who have symptoms consistent with the condition, as well as their family members who may be at risk of inheriting the disorder. It can help guide treatment decisions, provide information about prognosis, and assist in family planning.

It’s important to note that genetic testing for SPG55 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.